These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10905013)

  • 21. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
    Migliorati CA; Birman EG; Cury AE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):301-10. PubMed ID: 15356467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility patterns of Candida species recovered from Canadian intensive care units.
    Laverdiere M; Labbé AC; Restieri C; Rotstein C; Heyland D; Madger S; Stewart T
    J Crit Care; 2007 Sep; 22(3):245-50. PubMed ID: 17869976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
    Zaoutis TE; Foraker E; McGowan KL; Mortensen J; Campos J; Walsh TJ; Klein JD
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women.
    Ozcan SK; Budak F; Yucesoy G; Susever S; Willke A
    APMIS; 2006 Feb; 114(2):139-45. PubMed ID: 16519751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens.
    Ellabib MS; ElJariny IA
    Saudi Med J; 2001 Oct; 22(10):860-3. PubMed ID: 11744942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of yeasts implicated in vulvovaginal candidosis in Irish women.
    al-Rawi N; Kavanagh K
    Br J Biomed Sci; 1999; 56(2):99-104. PubMed ID: 10695049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Systemic yeast infections in a general hospital. Correlation between study of susceptibility in vitro and patient survival to the fungal infection episode].
    Tapia C; González P; Díaz MC; Corvalán V; Gaete M; Cuenca-Estrella M; Rodríguez-Tudela JL
    Rev Med Chil; 2002 Jun; 130(6):661-5. PubMed ID: 12194689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
    Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
    Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.
    Gualco L; Debbia EA; Bandettini R; Pescetto L; Cavallero A; Ossi MC; Schito AM; Marchese A
    Int J Antimicrob Agents; 2007 Feb; 29(2):179-84. PubMed ID: 17175140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004].
    Eloy O; Blanc V; Pina P; Gaudart A; Bressolle ML; Plainvert C; Decousser JW; Pangon B; Allouch PY;
    Pathol Biol (Paris); 2006; 54(8-9):523-30. PubMed ID: 17029814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
    Sangorrín MP; Lopes CA; Rivero A; Caballero AC
    Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan.
    Abu-Elteen KH
    Jpn J Infect Dis; 2001 Jun; 54(3):103-7. PubMed ID: 11544399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
    Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P
    J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the antifungal effect of a new propiconazole derivative against 64 yeast strains isolated from vaginal mycosis].
    Mareş M; Stefanache A; Popovici I; Valica V; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(3):768-72. PubMed ID: 18293715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.